WELLBUTRIN XL
BAUSCH HEALTH, CANADA INC.
Quick answers
Is there a shortage of WELLBUTRIN XL in Canada?
No. There is no current shortage of WELLBUTRIN XL 300MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
⚠ Extended-release and immediate-release formulations are not interchangeable — confirm the release type with your pharmacist before switching.
Closest Matches
TEVA-BUPROPION XL
TEVA CANADA LIMITED
Other Products
WELLBUTRIN SR
Extended-ReleaseBIOVAIL PHARMACEUTICALS CANADA DIVISION OF BIOVAIL CORPORATION
PMS-BUPROPION SR
Extended-ReleasePHARMASCIENCE INC
ZYBAN
BAUSCH HEALTH, CANADA INC.
ODAN BUPROPION SR
Extended-ReleaseODAN LABORATORIESLTD
WELLBUTRIN XL
BAUSCH HEALTH, CANADA INC.
DIN
02275104
Strength
300MG
Dosage Form
Tablet (Extended-Release)
Route
Oral
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from BAUSCH HEALTH, CANADA INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.